SCHEMBL9852831

SCHEMBL9852831

Cc1nc(C(=O)O)nc(C)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.41
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
TSHR P16473 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35
GABRA4 P48169 1/20 0.35
GABRE P78334 1/20 0.35
GABRA6 Q16445 1/20 0.35
GABRG1 Q8N1C3 1/20 0.35
GABRG3 Q99928 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22229724 0.85 PDE10A (0.36) PDE10AALDH1A1HPGDTSHRSMN1; SMN2
SCHEMBL24581549 0.84 ALDH1A1 (0.42) PDE10AALDH1A1HPGDTSHRSMN1; SMN2
SCHEMBL13531335 0.78 SMN1; SMN2 (0.42) PDE10AALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL13998897 0.77 NPSR1 (0.48) ALDH1A1HPGDSMN1; SMN2KDM4EL3MBTL1
SCHEMBL28456316 0.76 MAPK1 (0.43) PDE10AALDH1A1HPGDSMN1; SMN2MAPK1
SCHEMBL14434338 0.74 SMN1; SMN2 (0.47) PDE10AALDH1A1HPGDTSHRSMN1; SMN2
SCHEMBL28478763 0.74 NPSR1 (0.50) ALDH1A1HPGDSMN1; SMN2TDP1KDM4E
SCHEMBL18179066 0.74 ALDH1A1 (0.44) PDE10AALDH1A1HPGDTSHRSMN1; SMN2
SCHEMBL3633436 0.72 SMN1; SMN2 (0.50) ALDH1A1HPGDSMN1; SMN2MAPK1KDM4E
Potassium SCHEMBL30932480 0.72 TSHR (0.36) ALDH1A1TSHRSMN1; SMN2MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240032421-A1 Charge Transporting Material, Organic Electroluminescent Element, Light Emitting Device, Display Device And Illumination Device UDC IRELAND LIMITED (IE) 2024-01-25 US disclosed
US-11800798-B2 Charge transporting material, organic electroluminescent element, light emitting device, display device and illumination device UDC IRELAND LIMITED (IE) 2023-10-24 US disclosed
US-20180145264-A1 Organic Electroluminescent Device; A Charge Transporting Material For The Organic Electroluminescent Device; And A Luminescent Device, A Display Device And A Lighting System Using The Organic Electroluminescent Device UDC IRELAND LTD (IE) 2018-05-24 US disclosed
US-9306176-B2 Organic electroluminescent device; a charge transporting material for the organic electroluminescent device; and a luminescent device, a display device and a lighting system using the organic electroluminescent device UDC IRELAND LIMITED (IE) 2016-04-05 US disclosed
US-9000421-B2 Organic electroluminescent element, materials for organic electroluminescent element, and light emitting device, display device, or illumination device, each using the element, and compounds used in the element UDC IRELAND LIMITED (IE) 2015-04-07 US disclosed
US-20140034914-A1 Organic Electroluminescent Device; A Charge Transporting Material For The Organic Electroluminescent Device; And A Luminescent Device, A Display Device And A Lighting System Using The Organic Electroluminescent Device UDC IRELAND LIMITED (IE) 2014-02-06 US disclosed
EP-0444286-A1 Sulphonylated pyrimidine carboxylic acid amides BAYER AG (DE) 1991-09-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180145264-A1 Organic Electroluminescent Device; A Charge Transporting Material For The Organic Electroluminescent Device; And A Luminescent Device, A Display Device And A Lighting System Using The Organic Electroluminescent Device SLC43A1, SLC6A19, AOC3 PDE10A 4678/4885ALDH1A1 279/4885HPGD 3558/4885
US-11800798-B2 Charge transporting material, organic electroluminescent element, light emitting device, display device and illumination device TMEM109, SLC39A11, SLC39A14 PDE10A 2599/4885ALDH1A1 981/4885HPGD 4502/4885
US-20240032421-A1 Charge Transporting Material, Organic Electroluminescent Element, Light Emitting Device, Display Device And Illumination Device TMEM109, SLC39A11, SLC39A14 PDE10A 2599/4885ALDH1A1 981/4885HPGD 4502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.